Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Inhibrx Biosciences, Inc.

NASDAQ: INBX · Life Sciences · 4 alerts · CIK 2007919

Share price
$77.66Close, Nov 16
Market cap
$1.15B
Shares outstanding
14.77MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Inhibrx Biosciences, Inc. filings on SEC EDGAR ↗

6:58 PM ET Form 4
Insider Buying

Inhibrx Biosciences CEO Mark Lappe Buys $832K of Stock

Mark Lappe, CEO, bought 9,840 shares of Inhibrx Biosciences, Inc. at $84.07 to $85.00 a share (average $84.54) in 4 transactions, worth $832K in total on Oct 14, 2026. Shares held after the trade: 169,900 (+1.5%).

Value
$832K
Shares
9,840
Average price
$84.54
Role
CEO
Holding change
+1.5%
Trade date
Oct 14, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.